FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Potassium Phosphate Injection
Status: Currently in Shortage
»Date first posted: 04/14/2017
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology

Expand all

Fresenius Kabi USA, LLC (Revised 06/21/2017)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Phosphorus 15 mmol per 5 mL, Potassium 22 mEq per 5 mL,single dose vial (NDC 63323-086-05) Backordered. Next release anticipated June 2017. Demand increase for the drug
Phosphorus 45 mmol per 15 mL, Potassium 66 mEq per 15 mL, single dose vial (NDC 63323-086-15) Backordered. Next release anticipated July 2017. Demand increase for the drug
Phosphorus 150 mmol per 50 mL, Potassium 220 mEq per 50 mL, single dose vial (NDC 63323-086-50) Backordered. Next release anticipated July 2017. Demand increase for the drug

Hospira, Inc. (Revised 06/23/2017)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
3 mM P/ml; 45 mM P/15 mL Single Dose Glass Fliptop Vial (NDC 00409-7295-01) Next delivery: Late July 2017; Estimated recovery: Q3 2017 Shortage per manufacturer: Manufacturing Delay. Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English